Literature DB >> 9359933

Opinion of the EMEA on the potential risk associated with medicinal products in relation to bovine spongiform encephalopathy (BSE) (16 April 1996) and report from the Committee for Proprietary Medicinal Products (CPMP) on the 'Note for Guidance on minimizing the risk of transmitting animal spongiform encephalopathies via medicinal products' (15 April 1997).

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9359933

Source DB:  PubMed          Journal:  Adverse Drug React Toxicol Rev        ISSN： 0964-198X


× No keyword cloud information.
  5 in total

1.  Booster influenza vaccination does not improve immune response in adult inflammatory bowel disease patients treated with immunosuppressives: a randomized controlled trial.

Authors:  Hiroko Matsumoto; Satoko Ohfuji; Kenji Watanabe; Hirokazu Yamagami; Wakaba Fukushima; Kazuhiro Maeda; Noriko Kamata; Mitsue Sogawa; Masatsugu Shiba; Tetsuya Tanigawa; Kazunari Tominaga; Toshio Watanabe; Yasuhiro Fujiwara; Yoshio Hirota; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2015-02-12       Impact factor: 7.527

2.  Transplanted Umbilical Cord Mesenchymal Stem Cells Modify the In Vivo Microenvironment Enhancing Angiogenesis and Leading to Bone Regeneration.

Authors:  Maria Rosa Todeschi; Rania El Backly; Chiara Capelli; Antonio Daga; Eugenio Patrone; Martino Introna; Ranieri Cancedda; Maddalena Mastrogiacomo
Journal:  Stem Cells Dev       Date:  2015-03-18       Impact factor: 3.272

3.  Development of Animal-free, Protein-Free and Chemically-Defined Media for NS0 Cell Culture.

Authors:  Jinyou Zhang; David Robinson
Journal:  Cytotechnology       Date:  2005-06       Impact factor: 2.058

4.  Controlled Growth and the Maintenance of Human Pluripotent Stem Cells by Cultivation with Defined Medium on Extracellular Matrix-Coated Micropatterned Dishes.

Authors:  Chiemi Takenaka; Hiroshi Miyajima; Yusuke Yoda; Hideo Imazato; Takako Yamamoto; Shinichi Gomi; Yasuhiro Ohshima; Kenichi Kagawa; Tetsuji Sasaki; Shin Kawamata
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

Review 5.  Validation of biopharmaceutical purification processes for virus clearance evaluation.

Authors:  Allan Darling
Journal:  Mol Biotechnol       Date:  2002-05       Impact factor: 2.695
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.